sprite-preloader
Freitag, 25.04.2014 Börsentäglich über 12.000 News von 475 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 882807 ISIN: US92532F1003 Ticker-Symbol: VX1 
Aktie:
Branche
Pharma
Aktienmarkt
NASDAQ-100
S&P 500
NASDAQ Biotech
1-Jahres-Chart
VERTEX PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
VERTEX PHARMACEUTICALS INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
47,76
47,94
24.04.
47,753
47,951
24.04.

Aktuelle News zu VERTEX PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
VERTEX PHARMACEUTICALS Aktie jetzt ab 5 Dollar handeln!

--> Artikel lesen
DoE-Commerce China Dangdang, Groupon, Microsoft, Vertex PharmaceuticalsandAlign Technology highlighted as Zacks Bull and Bear of the Day14
CHICAGO, April 24, 2014 /PRNewswire/ --Zacks Equity Research highlights E-Commerce China Dangdang (NYSE:DANG-Free Report) as the Bull of the Day and Groupon (Nasdaq:GRPN-Free Report) as the Bear of...
--> Artikel lesen
MiVertex Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Lowest Earnings Yield13

--> Artikel lesen
DiVertex Pharmaceuticals has the Lowest Operating Margin in the Biotechnology Industry10

--> Artikel lesen
15.04.Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma103
LONDON, April 15, 2014 /PRNewswire/ -- On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91%, to finish the day at 16,173.24...
--> Artikel lesen
12.04.Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Today's 3 Worst St38

--> Artikel lesen
10.04.Vertex Pharmaceuticals Crosses Below its 10-day MA11

--> Artikel lesen
03.04.Holaira Closes $42 Million Venture Financing Round / Investment Led by Vertex Venture Holdings to Support Randomized Clinical Trial29
MINNEAPOLIS, MN -- (Marketwired) -- 04/03/14 -- Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, today announced the completion of its Series D private equity financing...
--> Artikel lesen
29.03.Why Biogen Idec, Vertex Pharmaceuticals, and PG&E Are Today's 3 Worst Stocks65

--> Artikel lesen
28.03.Watch for Vertex Pharmaceuticals to Potentially Rebound After Falling 4.21% Yesterday4

--> Artikel lesen
28.03.Vertex Pharmaceuticals Falls 4.21% on Heavy Volume: Watch For Potential Rebound7

--> Artikel lesen
26.03.Biotech Stocks Technical Review -- Research on BioCryst Pharma, Spectrum Pharma, BioMarin Pharma, and Vertex Pharma50
LONDON, March 26, 2014 /PRNewswire/ -- On Tuesday, March 25, 2014, the NASDAQ Composite ended at 4,234.27, up 0.19%, the Dow Jones Industrial Average advanced 0.56% to 16,367.88, and the S&P 500...
--> Artikel lesen
25.03.Relatively Low Earnings Yield Detected in Shares of Vertex Pharmaceuticals in the Biotechnology Industry11

--> Artikel lesen
24.03.Vertex Pharmaceuticals Falls 1.88% on Heavy Volume: Watch For Potential Rebound-

--> Artikel lesen
24.03.Look for Shares of Vertex Pharmaceuticals to Potentially Rebound after Yesterday's 1.88% Sell Off4

--> Artikel lesen
24.03.Shares of Vertex Pharmaceuticals Rank the Lowest in Terms of Operating Margin in the Biotechnology Industry9

--> Artikel lesen
19.03.Vertex Pharmacueticals Inc Approaching a Huge Fork in the Road27

--> Artikel lesen
14.03.Uptrend Call Working As Vertex Pharmaceuticals Stock Rises 12.3%14

--> Artikel lesen
08.03.The Spark of Innovation at Vertex Pharmaceuticals Incorporated22

--> Artikel lesen
07.03.Look for Shares of Vertex Pharmaceuticals to Potentially Rebound after Yesterday's 3.64% Sell Off10

--> Artikel lesen
07.03.Watch for Vertex Pharmaceuticals to Potentially Rebound After Falling 3.64% Yesterday8

--> Artikel lesen
Seite:  Weiter >>
141 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
VERTEX PHARMACEUTICALS INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
GILEAD SCIENCES52,94-2,29 %Gilead Sciences-Aktie: Quartalszahlen dank Solvadi au
San Francisco - Gilead Sciences-Aktienanalyse von Analyst Brian Abrahams von Wells Fargo Advisors: Der Aktienanalyst Brian Abrahams von Wells Fargo Advisors stuft die Aktien des US-Biotechkonzerns Gilead...
--> Artikel lesen
CELGENE101,18-4,55 %Celgene Q1 Adj. Profit Tops View, Backs 2014 View
SUMMIT (dpa-AFX) - Drug maker Celgene Corp. (CELG) reported first-quarter net income of $279.7 million or $0.66 per share, down from $384.9 million or $0.89 per share in the prior-year quarter.Adjusted...
--> Artikel lesen
STADA ARZNEIMITTEL30,645+0,96 %Osram, Zinsen, Stada, Mifa, Facebook - unser Wochenrückblick
Die Börsen halten bis Dienstag ihren Osterschlaf, während die Autobranche mit großen Augen nach China schaut. Heute startet dort die Peking Auto-Show, und die Hersteller nutzen die Chance, sich dem...
--> Artikel lesen
PDL BIOPHARMA6,112-1,53 %Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma
LONDON, April 8, 2014 /PRNewswire/ -- On Monday, April 07, 2014, the NASDAQ Composite ended at 4,079.75, down 1.16%, the Dow Jones Industrial Average finished the session 1.02% lower at 16,245.87...
--> Artikel lesen
PFIZER22,235-0,43 %Pfizer scheitert mit Gigant-Übernahme
  Heiko Weyand, Zertifikate-Experte, HSBC Trinkaus Pfizer scheitert mit Gigant-Übernahme   In der Pharmabranche...
--> Artikel lesen
Lade...